Silence Therapeutics plc SLN
19.78 USD 0.00 (+0.00%)
Nov 4, 2026, 2:34 PM EST
19.75 Day range 19.81
4.19 52-week range 19.87
- YTD
- +225.33%
- 1 year
- +203.84%
Analyst view
Consensus: hold
Hold
Price target (mean) 19.75 -0.2% downside
Now 19.78
- Target (low)
- 19.00
- Target (mean)
- 19.75
- Target (high)
- 20.00
Ratings (0m) 5 1 buy · 4 hold · 0 sell
- Strong buy0
- Buy1
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 7
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.09 – -0.09 | -0.15 | +40.0% | 20.83K | -82.8% | 1 |
| Next quarter | -0.10 | -0.10 – -0.10 | -0.27 | +63.0% | 4.50K | -82.3% | 1 |
| Current year | -0.365 | -0.37 – -0.36 | -1.85 | +80.3% | 328.76K | -21.4% | 2 |
| Next year | -0.38 | -0.38 – -0.38 | -0.365 | -4.1% | 760.45K | +131.3% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 24, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 17, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 8, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Jun 13, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 13, 2025 | Chardan Capital | Maintained | Buy | Buy |
| May 9, 2025 | Goldman Sachs | Maintained | Sell | Sell |
| May 9, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 9, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Mar 7, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 5, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 4, 2025 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 4, 2025 | Goldman Sachs | Maintained | Sell | Sell |
| Feb 11, 2025 | Goldman Sachs | Initiated | — | Sell |
| Feb 3, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 29, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 10, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Dec 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 14, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 8, 2024 | Morgan Stanley | Reiterated | Overweight | Overweight |
| Aug 30, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 16, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Jun 28, 2024 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 28, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Jun 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |